Associate Health Minister David Seymour warns Pharmac to modernise or risk falling behind
RNZ
The Associate Health Minister says Pharmac must modernise, "or it will fall behind."
David Seymour has told the agency to "innovate and optimise" to increase access to medicines and continue the "positive culture shift" that's been underway, such as exploring ways to "utilise AI".
Seymour released his latest letter of expectations today, with the hope of building on his letter from last year where he told the agency it was
inappropriate to keep considering the Treaty of Waitangi's place
in the health sector.
Since that letter of expectation, Seymour said the drug-buying agency has improved overall consultation and changed funding criteria based on public feedback.
The agency had also appointed a new chief executive to "cement positive change, and continue to move towards a more transparent, inclusive, and people-focused organisation."
"This is a good start. My letter of expectations for this year makes it very clear that there is still more work to be done. I expect this positive culture shift to continue," Seymour said.
Now, Seymour wanted Pharmac to modernise and "adopt faster, smarter processes and explore the use of AI to lift performance."
His expectations included:
Seymour told the agency he wanted it to report back to him by December this year on work done to consider the broader fiscal impacts to government and regarding societal and non-health outcomes of funding medicines and medical devices.
He also expected Pharmac to "renew its organisational culture and sharpen its strategic focus, ensuring it plays a more visible and constructive role across the wider health system."
As part of the "continuous improvement of organisational culture", Seymour said Pharmac needed to carry on giving effect to the Cabinet Circular specifying "Needs-based Service Provision" to meet the government's expectations for how the "targeting, commissioning and design of public services should be based on the needs of all New Zealanders."
Seymour said he's committed to ensuring the regulatory system for pharmaceuticals was not "unreasonably holding back access".
Sign up for Ngā Pitopito Kōrero
,
a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
RNZ News
7 hours ago
- RNZ News
Medsafe considers crackdown on import of unregulated peptide medications
Medsafe says people are buying unregulated peptides from websites that make health claims for which there is little or no evidence. Photo: Science Photo Li / WBU / Science Photo Library via AFP New Zealanders are buying potentially high-risk, unregulated peptide medications from overseas websites to treat sexual dysfunction, memory loss and more. Medsafe is considering a crackdown, warning many are sold based on unproven claims. It hopes to have several of them - and similar ones that may crop up - classified as prescription medicines, making it illegal to import them without a prescription. In a written submission to the Medicines Classification Committee, Medsafe said peptides were being bought from websites that made claims they could help with "cognitive enhancement, hair growth, libido enhancers, sexual dysfunction, immune enhancers and cancer treatment", and more. However, there was often little, if any, evidence to back up the claims. Most had not been tested for safety and efficacy on humans. Medsafe could not seize peptides at the border, if they were not classed as prescription medicine. Instead, it released the products to the purchasers with a "high-risk medicine letter". "This is posing a risk to health, as the product's quality, efficacy and interactions with other medicines is unknown," the submission said. Because new peptide substances were created all the time, Medsafe asked the committee to class whole groups of them as prescription medicines, so future versions that fell within the group would still be covered. Many websites that sold peptides claimed to sell them "for research purposes", but customers intended to use them therapeutically, the submission said. Fifty-six parcels were intercepted at the border in the year to May, containing peptides or prescription medications known as selective androgen receptor modulators (SARMS). Customs said it couldn't say how many got through without interception. Medsafe said the classification review would take into consideration the safety and appropriateness of being able to import these products, as well the risks of limiting access. The committee considered the submission at a meeting on Wednesday and its decision has not been made public yet. The final decision on medicine classification changes will be made by the Minister of Health at the committee's recommendation. Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
RNZ News
20 hours ago
- RNZ News
Social media age restriction needed to protect young people from harm
ABC social media graphic. Photo: Supplied/ABC A University of Auckland senior research fellow is calling for social media platforms to introduce enforced age limits, to help protect young people from harm. A briefing from the Public Health Communication Centre has outlined growing evidence social media use is linked to a range of mental and physical health problems. It highlights policy options for addressing these harms, including restricting access to social media for those under 16. Currently, the age limit to join the majority of platforms like Facebook, Instagram and Snapchat is 13, but it is not enforced. "Introducing an age restriction is the only comprehensive measure that addresses the full range of social media-related harms to young people," said author Dr Samantha Marsh. "It also empowers parents to set boundaries and shift social norms in a positive direction." Marsh said while social media may offer some benefits for some young people, such as helping connect with peers and find support, she warned these must be weighed carefully against mounting evidence of harm. "There's a huge imbalance. The weight of evidence showing that these platforms can negatively affect youth mental health has become too great to ignore," she said. "We now have years of consistent findings: young people who spend more time on social media are more likely to experience depression, anxiety, and disrupted sleep. "These findings come not only from surveys, but also from longitudinal studies, randomised trials, and robust systematic reviews." Marsh said any changes to social media access should be accompanied by a coordinated effort to provide on and offline support for vulnerable youth, as well as empowering communication campaigns. The briefing's release coincides with the government's inquiry into online harms experienced by young people, which is currently open for public consultation, with submissions closing on 30 July . Marsh said the inquiry was a vital opportunity to build healthier digital environments. "Political decision-makers now have a strong enough evidence base to act. Delaying access to social media and supporting youth and whānau through a coordinated public health response is the path forward."
RNZ News
2 days ago
- RNZ News
Hysteroscopy outpatient service at North Shore Hospital to speed up diagnosis
North Shore Hospital in Auckland. Photo: rafaelbenari/123RF A new outpatient hysteroscopy service at Auckland's North Shore Hospital will help gynaecological patients get a faster diagnosis. Health Minister Simeon Brown said it combines their first specialist assessment (FSA) and diagnostic procedure into a single visit. "This is a practical, patient-focused pathway that means women can get the answers they need sooner, without the stress and delays of multiple appointments or hospital admission," Brown said. A hysteroscopy is a procedure used to look inside the womb (uterus) and at the lining of the womb. A sample (biopsy) of the lining is usually taken as part of a diagnostic hysteroscopy, to look for abnormalities. Patients with symptoms such as abnormal vaginal bleeding, irregular periods and infertility might be referred for a hysteroscopy. "Previously, women needing a hysteroscopy would attend an initial specialist appointment and then wait weeks to undergo the procedure in theatre under general anaesthetic." Brown said the new approach removed that delay for women suitable for the treatment. "Now, women needing an uncomplicated hysteroscopy procedure can choose to have both the specialist assessment and the procedure in a single outpatient appointment. "That means fewer hospital visits, less time off work or away from family, and a much more streamlined experience. "For women with a high suspicion of cancer, this pathway can reduce the diagnostic timeline by two to six weeks compared to traditional models. That time could make all the difference." Health Minister Simeon Brown. Photo: RNZ / REECE BAKER North Shore Hospital expects to deliver around 60 outpatient hysteroscopy clinics over the next 12 months, with approximately 240 procedures. "Every outpatient procedure frees up valuable theatre space and clinical teams for patients who require more complex surgery. That's better for patients, and better for the whole system," Brown said. The new service meant a significant proportion of uncomplicated hysteroscopies that would have otherwise been performed in theatre under anaesthesia can now be done safely as outpatient procedures. "This is part of a regional effort to improve the quality, timeliness, and experience of care for women undergoing investigation for gynaecological cancers. "It will also play an important role in meeting our faster cancer treatment target by speeding up diagnosis and helping women start treatment sooner." The new service followed similar successful models already operating in Auckland, Counties Manukau, and Waikato. Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
